Latest Schedule 13G passive stakes

ADAR1 Capital Management, LLC and Daniel Schneeberger have jointly filed a Schedule 13G, reporting beneficial ownership of 7.0% of Cyclerion Therapeutics, Inc. common stock as of June 30, 2026.

ADAR1 Capital Management and Daniel Schneeberger have filed a joint Schedule 13G, reporting beneficial ownership of 8.8% of Boundless Bio, Inc. common stock as of June 30, 2026.

ADAR1 Capital Management, LLC and Daniel Schneeberger have jointly filed a Schedule 13G, disclosing beneficial ownership of 9.6% of Amanat Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

CP BF Lending, LLC has filed a Schedule 13G, disclosing beneficial ownership of 1,079,713 shares of Banzai International's Class A common stock, representing 24.8% of the outstanding shares.

Ikarian Capital, LLC and Neil Shahrestani have filed a Schedule 13G, reporting beneficial ownership of 9.9% of CNS Pharmaceuticals, Inc. common stock.

Ikarian Capital, LLC and Neil Shahrestani have reported a beneficial ownership of 6.9% in Connect Biopharma Holdings Limited's ordinary shares.

Ikarian Capital, LLC and Neil Shahrestani have reported beneficial ownership of 9.0% of Quince Therapeutics, Inc. common stock as of June 30, 2026.

Ikarian Capital, LLC and Neil Shahrestani have jointly filed a Schedule 13G, reporting beneficial ownership of 9.5% of Traws Pharma, Inc.'s common stock, including shares issuable upon warrant exercise.

Ikarian Capital, LLC and Neil Shahrestani have filed a Schedule 13G, reporting beneficial ownership of 1,080,700 shares, representing 2.9% of Tenax Therapeutics, Inc.'s common stock.

Ikarian Capital, LLC and Neil Shahrestani have reported beneficial ownership of 4.2% of InMed Pharmaceuticals Inc. common shares, totaling 137,634 shares.

Ikarian Capital, LLC and Neil Shahrestani have reported a complete divestment of their holdings in Galera Therapeutics, Inc., indicating a significant shift in their investment strategy.

Ikarian Capital, LLC and Neil Shahrestani have jointly reported a beneficial ownership of 4.9% in Kazia Therapeutics Limited's American Depositary Shares.

A Schedule 13G filing details the beneficial ownership of Yesway, Inc. Class A Common Stock as of June 30, 2026, by Thomas N. Trkla and associated entities.

Eric Remer, an executive at EverCommerce Inc., has reported beneficial ownership of 13,734,185 shares, representing 7.5% of the company's common stock as of June 30, 2026.

Ikarian Capital, LLC and Neil Shahrestani have filed a Schedule 13G, reporting beneficial ownership of 9.99% of NextCure, Inc.'s common stock, including potential shares from warrants.

General Atlantic entities have collectively adjusted their beneficial ownership of Pharvaris N.V. ordinary shares to 7.6%, as reported in an amended Schedule 13G filing.

Silver Point Capital, L.P. has filed an exit statement indicating it no longer holds any beneficial ownership of Smart Share Global Limited's Class A ordinary shares.

Zazove Associates, LLC, along with Zazove Associates, Inc. and Gene T. Pretti, have reported beneficial ownership of 247,866 shares, representing 8.0% of Braemar Hotels & Resorts Inc.'s Series B Convertible Preferred Stock.

Charles A. Davis, President and CEO of Ellipse Holdings LLC, has reported beneficial ownership of 16,522,133 shares, representing 7.3% of Beta Technologies, Inc.'s Class A common stock.

Berkshire Hathaway Inc. and its subsidiaries have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 8.7% of Delta Air Lines, Inc. common stock as of June 30, 2026.

Berkshire Hathaway Inc. and its subsidiaries have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 8.7% of Delta Air Lines, Inc. common stock as of June 30, 2026.

Berkshire Hathaway Inc. and its affiliates have reported a beneficial ownership of 6.2% of Lennar Corporation's common stock as of June 30, 2026.

Berkshire Hathaway Inc. and its affiliates have reported a beneficial ownership of 6.2% of Lennar Corporation's common stock as of June 30, 2026.

Several Bayview-affiliated entities have reported a combined beneficial ownership of 8.7% of Forbright Inc.'s Class A Common Stock as of August 14, 2026.

Zazove Associates, LLC, Zazove Associates, Inc., and Gene T. Pretti have jointly reported beneficial ownership of 5,210,486 shares, representing 7.6% of Braemar Hotels & Resorts Inc.'s common stock.

Paul B. Manning and associated entities report beneficial ownership of 6.5% of Liquidia Corp's common stock as of June 30, 2026, with no changes in reporting status.

Aldersgate Capital Partners Ltd. and Jason Thomas Kelly Butcher have filed an exit statement, confirming they no longer beneficially own more than 5% of Perpetuals.com Ltd. shares.

Nathan Blecharczyk and Gioacchino Curiale have disclosed substantial beneficial ownership of Airbnb's Class A Common Stock, totaling over 60 million shares.

Altimeter Capital Management, LP, along with its affiliates, has updated its beneficial ownership filing for Cerebras Systems Inc., reporting a 6.2% stake as of August 14, 2026.

Joseph Gebbia has reported beneficial ownership of 33,764,227 shares of Airbnb's Class A Common Stock, representing 7.5% of the class, as of June 30, 2026.